Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant CEV Chemotherapy for Stage I Retinoblastoma
NCT05080010Phase 3Recruiting
- Sponsor
- Sun Yat-sen University
- Start
- Nov 2020
- Primary completion
- Dec 2030
- Modality
- DNA Intercalators/Alkylators, Covalent Small Molecules, Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of vincristine, carboplatin, etoposide in retinoblastoma (Rb), sponsored by Sun Yat-sen University. Started Nov 2020; status: recruiting.
02
Drugs
vincristinecarboplatinetoposide
03
Conditions
retinoblastoma (Rb)
Beyond the preview
Go deeper on NCT05080010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05080010.